(Q33402824)

English

Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

0 references

chronic heart failure

1 reference

based on heuristic

inferred from title

Christopher B. Granger

10

object named as

Christopher B Granger

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

6

object named as

Karl Swedberg

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

8

object named as

Salim Yusuf

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

2

object named as

G Michael Felker

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

4

object named as

John J V McMurray

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

5

object named as

Marc A Pfeffer

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Eric L Michelson

9

object named as

Eric L Michelson

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

7

object named as

Duolao Wang

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1

object named as

Larry A Allen

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

CHARM Investigators and Committees

11

object named as

CHARM Investigators

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Stuart Pocock

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

1 February 2009

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

170-177

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639422

28 July 2018

The Seattle Heart Failure Model: prediction of survival in heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639422

28 July 2018

Predictors of mortality and morbidity in patients with chronic heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639422

28 July 2018

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639422

28 July 2018

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639422

28 July 2018

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639422

28 July 2018

The liver in heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639422

28 July 2018

Ischemic hepatitis: clinical presentation and pathogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639422

28 July 2018

Heart diseases affecting the liver and liver diseases affecting the heart

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2639422

28 July 2018

Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN031

21 January 2018

Worsening renal function and prognosis in heart failure: systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN031

21 January 2018

The liver in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN031

21 January 2018

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN031

21 January 2018

Comparison of mortality rates and progression of left ventricular dysfunction in patients with idiopathic dilated cardiomyopathy and dilated versus nondilated right ventricular cavities.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN031

21 January 2018

Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN031

21 January 2018

Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFN031

21 January 2018

Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19168515

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics

1 reference

https://pubmed.ncbi.nlm.nih.gov/19168515

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/19168515

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19168515

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High serum transaminase activity in heart disease. Circulatory failure and hepatic necrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19168515

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/EURJHF/HFN031

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33402824&oldid=1744703942"